Class A CpG oligodeoxynucleotide inhibits IFN‐γ‐induced signaling and apoptosis in lung cancer

BACKGROUND: Currently, anticancer immunotherapy based on PD‐1/PD‐L1 blockade with immune checkpoint inhibitors (ICIs) is being used as a standard therapy for non‐small cell lung cancer (NSCLC). However, more effective treatments are required as these tumors are often resistant and refractory. Here,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Thorac Cancer
Autors principals: Teranishi, Shuhei, Kobayashi, Nobuaki, Katakura, Seigo, Kamimaki, Chisato, Kubo, Sousuke, Shibata, Yuji, Yamamoto, Masaki, Kudo, Makoto, Piao, Hongmei, Kaneko, Takeshi
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons Australia, Ltd 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113052/
https://ncbi.nlm.nih.gov/pubmed/32067413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13351
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars